Goldman Sachs’s INVO Fertility Inc IVF Stock Holding History

Goldman Sachs’s Portfolio IVF Stock Details IVF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1	Closed	-$49K	–	6403
2020 Q4	$49K	Buy	+1	New	+$90.6K	﹤0.01%	5386

Other funds holding IVF

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CIS

Connors Investor Services Wyomissing, Pennsylvania $1.08B AUM 31.31% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Goldman Sachs's IVF Position: Q1 2021 in Review

Goldman Sachs sold out of INVO Fertility Inc (IVF) in Q1 2021, closing a stake of 1 share — an estimated $49K sold.

Goldman Sachs first reported a position in IVF in Q4 2020 and held it in 1 quarter. The position peaked at $49K in Q4 2020. 7 funds tracked by Wall St. Rank hold IVF as of Q1 2021.

Goldman Sachs reported no remaining INVO Fertility Inc position as of Q1 2021 after selling out during the quarter.
Goldman Sachs sold 1 INVO Fertility Inc share in Q1 2021, an estimated $49K.
Goldman Sachs first reported a position in INVO Fertility Inc in Q4 2020 and held it in 1 quarter.
Goldman Sachs's INVO Fertility Inc position peaked at $49K in Q4 2020.
7 funds tracked by Wall St. Rank held INVO Fertility Inc as of Q1 2021.

Based on Goldman Sachs's 13F filing for Q1 2021, filed 17 May 2021.